Search clinical trials for: Moxifloxacin (Avelox, BAY12-8039)

Total 129 results

Bayer

Completed

Bioavailability, Food Effect and Safety, Tolerability of a New Oral Suspension in Comparison to the Marketed Moxifloxacin Tablet in Healthy Adults

Healthy

Germany
Bayer

Completed

Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox (SPEED)

Maxillary Sinusitis

United States, Argentina
Bayer

Completed

BAY12-8039: 5 Days for Sinusitis vs Placebo

Sinusitis

United States
Bayer

Completed

Greatest International Antiinfective Trial With Avelox (GIANT)

Bronchial Diseases | Bronchitis, Chronic

Switzerland, Poland, China, Croatia, Germany, Hungary, Indonesia, Korea, Republic of, Malaysia, Singapore, Philippines, Taiwan, Austria, Colombia, Hong Kong, Mexico, Slovenia, Turkey, Egypt, Morocco, Netherlands, Pakistan, Brazil, El...
Bayer

Completed

Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients

Infections

United States
Bayer

Completed

Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease

Anti-Infective Agents

Japan
Bayer

Completed

Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis

Lung Diseases | Bronchitis, Chronic

Italy, Spain, United States, Greece, Chile, Germany, France, Mexico, Argentina, Israel, South Africa, Ireland, Brazil, United Kingdom, Andorra
Bayer

Completed

SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe Acute Exacerbations of Chronic Bronchitis (AECB) (SYMPROVE III)

Chronic Bronchitis

Germany
Bayer

Completed

Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)

Abscess, Intra-Abdominal | Secondary Peritonitis

China
Bayer

Completed

Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control Validation

Electrocardiography | QTc Evaluation

Singapore, Australia, Germany, United Kingdom
Bayer

Completed

Treatment of Patients With Acute Sinusitis

Acute Bacterial Sinusitis

China, France, Germany, Indonesia, Malaysia, Saudi Arabia, Singapore, Philippines, Austria, Jordan, Lebanon, Romania, Bahrain, Egypt, United Arab Emirates, Kuwait, Netherlands, Pakistan, Yemen
Bayer

Completed

CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized Patients

Pneumonia

Croatia, France, Hungary, Jordan, Kazakhstan, Lebanon, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Romania, Russian Federation, Ukraine
Bayer

Completed

Avelox in Complicated Skin and Skin Structure Infections (ARTOS)

Skin Diseases, Bacterial

Germany, Indonesia, Korea, Republic of, Saudi Arabia, Philippines, Taiwan, Austria, Bulgaria, Slovenia, Egypt, Greece, Pakistan
Bayer

Completed

VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis (VICTOR)

Chronic Bronchitis | Disease Exacerbation

China
Bayer

Completed

AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs

Bronchitis, Chronic

Slovakia, Kazakhstan, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Russian Federation, Ukraine, Bosnia and Herzegovina, Albania
Bayer

Completed

BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia

Pneumonia, Aspiration | Lung Abscess

Germany
Bayer

Completed

A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs (MERAK)

Infectious Diseases

Italy
Bayer

Completed

Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem

Infection

Belgium, France, Argentina, Spain, Germany, Israel, Romania, Bulgaria, Russian Federation, Lithuania, South Africa, Latvia, Greece, Estonia
Bayer

Completed

Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections) (DRAGON)

Infection, Intra-abdominal

China, Hong Kong, Indonesia, Korea, Republic of, Malaysia, Taiwan
Bayer

Completed

Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia

Pneumonia

United States, Puerto Rico
Bayer

Terminated

Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis

Bacterial Infections | Sinusitis

Italy
Bayer

Completed

Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin. (MAIDEN)

Pelvic Inflammatory Disease

Germany, Italy, France, Hungary, Sweden, Poland, South Africa, Russian Federation, Finland, Denmark, Lithuania, United Kingdom, Greece
Bayer

Completed

Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis

Chronic Bronchitis

Spain, China, Argentina, Germany, Greece, Portugal, Canada, Netherlands, Australia, Peru, Philippines, Belgium, Switzerland, Chile, Italy, Thailand, Mexico, Lithuania, South Africa, Croatia, France, Colombia, Indonesia, Latvia, Hong Kong, United Kingdom and more
Bayer

Completed

Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection (MOXIPEDIA)

Intraabdominal Infections

Greece, Peru, United States, Chile, Bulgaria, Canada, Russian Federation, Lithuania, Germany, Hungary, Latvia, Romania, Ukraine, Czechia, Argentina, Mexico
Bayer

Completed

Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection

Diabetic Foot | Ulcer | Abscess | Wound Infection

Italy, Spain, Greece, Ireland, Russian Federation, United Kingdom, Germany, Austria, Belgium, France, Hungary, South Africa, Romania, Bulgaria, Poland, Israel, Latvia, Ukraine, Lithuania, Netherlands
Bayer

Completed

Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects

Healthy

United States
Bayer

Completed

Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia

Pneumonia

Belgium, Germany, Spain, Greece, France, Netherlands, Chile, Mexico, Poland, South Africa, United Kingdom, Argentina, Colombia, Israel, Lithuania, Peru, Portugal, Sweden
Bayer

Completed

A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease

Pelvic Inflammatory Disease

China, Philippines, Thailand, Pakistan, Taiwan, Indonesia, Korea, Republic of
Global Alliance for TB Drug Development

Completed

A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis. (NC-005)

Tuberculosis

Tanzania, South Africa, Uganda
Bayer

Completed

A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia

Pneumonia

Italy
Massachusetts General Hospital

Terminated

Genetics of QT Response to Moxifloxacin (MOXIGEN)

Cardiac Arrhythmias

United States
Dr. Reddy's Laboratories Limited

Completed

Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions

Healthy
Medecins Sans Frontieres, Netherlands
London School of Hygiene and Tropical Medicine; University College, London; University... and other collaborators

Active, not recruiting

PRACTECAL-PKPD Sub Study (PRACTECAL-PKPD)

Multi-drug Resistant Tuberculosis | Pulmonary Tuberculosis | Extensively Drug-Resistant Tuberculosis

Belarus, South Africa
Centre for the AIDS Programme of Research in South...

Completed

Improving Retreatment Success (IMPRESS) (IMPRESS)

Recurrent Tuberculosis

South Africa
University of Cologne

Completed

Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells (MoxiProph)

Multiple Myeloma | Hodgkin Disease | Bacteremia | Non-Hodgkin Lymphoma

Germany
Kaohsiung Veterans General Hospital.
Bayer

Completed

Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess

Liver Abscess

Taiwan
Global Alliance for TB Drug Development

Completed

Shortening Treatment by Advancing Novel Drugs (STAND)

Tuberculosis, Pulmonary, Drug Sensitive | Tuberculosis, Pulmonary, Multi Drug-resistant

South Africa, Zambia, Georgia, Philippines, Kenya, Malaysia, Tanzania, Uganda
Global Alliance for TB Drug Development
Sanofi; University College, London; European and Developing Countries Clinical... and other collaborators

Completed

Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis (REMoxTB)

Pulmonary Tuberculosis

China, Zambia, Tanzania, India, Kenya, Malaysia, Mexico, South Africa, Thailand
Bayer
RTI Health Solutions

Completed

Risk of Acute Liver Injury in Users of Antimicrobials

Drug-Induced Liver Injury

United States
University Hospital, Saarland
Bayer

Completed

Penetration of Moxifloxacin Into Liver Tissue of Patients Undergoing Liver Resection. (MOXI)

Side-effect of Antibiotic

Germany
Medecins Sans Frontieres, Netherlands
London School of Hygiene and Tropical Medicine; University of Liverpool; Ministry... and other collaborators

Recruiting

Economic Evaluation of New MDR TB Regimens (PRACTECAL-EE)

Multi-drug Resistant Tuberculosis | Pulmonary Tuberculoses | Extensively Drug-Resistant Tuberculosis

Belarus, South Africa, Uzbekistan
Medecins Sans Frontieres, Netherlands
London School of Hygiene and Tropical Medicine; University of Sussex; Ministry... and other collaborators

Recruiting

Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial (PRACTECAL-PRO)

Multidrug Resistant Tuberculosis

Belarus, South Africa, Uzbekistan
Paratek Pharmaceuticals Inc
Novartis Pharmaceuticals

Terminated

Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) (CSSI)

Skin Diseases, Infectious

United States
Furiex Pharmaceuticals, Inc

Terminated

Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia

Community-Acquired Bacterial Pneumonia (CABP)

United States, Canada, Colombia, Germany, Hungary, Poland
Universitas Padjadjaran
Radboud University Medical Center

Completed

Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study

Pharmacokinetics | Pharmacodynamics | Tolerability | Meningitis, Tuberculous

Indonesia
Mylan Inc.
Theravance Biopharma

Completed

Thorough QT (TQT) Study of TD-4208 in Healthy Subjects

Cardiac Repolarization in Healthy Subjects

United States
Johns Hopkins University

Completed

Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis

Tuberculosis

Brazil
Connect Biopharma Australia Pty Ltd

Completed

A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects

Autoimmune Diseases

Australia, United States
Pfizer

Completed

A Study To Assess The Effect Of Linezolid On QTc Interval

Bacterial Infections

Singapore
Boehringer Ingelheim

Completed

Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects.

Healthy

Germany

Search clinical trials for: Moxifloxacin (Avelox, BAY12-8039)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations